These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33694043)

  • 1. Performance comparison: exome sequencing as a single test replacing Sanger sequencing.
    Fridman H; Bormans C; Einhorn M; Au D; Bormans A; Porat Y; Sanchez LF; Manning B; Levy-Lahad E; Behar DM
    Mol Genet Genomics; 2021 May; 296(3):653-663. PubMed ID: 33694043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants.
    Beck TF; Mullikin JC; ; Biesecker LG
    Clin Chem; 2016 Apr; 62(4):647-54. PubMed ID: 26847218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an evidence-based algorithm that optimizes sensitivity and specificity in ES-based diagnostics of a clinically heterogeneous patient population.
    Bauer P; Kandaswamy KK; Weiss MER; Paknia O; Werber M; Bertoli-Avella AM; Yüksel Z; Bochinska M; Oprea GE; Kishore S; Weckesser V; Karges E; Rolfs A
    Genet Med; 2019 Jan; 21(1):53-61. PubMed ID: 30100613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of SureSelect and Nextera Exome Capture Performance in Single-Cell Sequencing.
    Huss WJ; Hu Q; Glenn ST; Gangavarapu KJ; Wang J; Luce JD; Quinn PK; Brese EA; Zhan F; Conroy JM; Paragh G; Foster BA; Morrison CD; Liu S; Wei L
    Hum Hered; 2018; 83(3):153-162. PubMed ID: 30669152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison and evaluation of two exome capture kits and sequencing platforms for variant calling.
    Zhang G; Wang J; Yang J; Li W; Deng Y; Li J; Huang J; Hu S; Zhang B
    BMC Genomics; 2015 Aug; 16(1):581. PubMed ID: 26242175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing in the rat.
    Foley JF; Phadke DP; Hardy O; Hardy S; Miller V; Madan A; Howard K; Kruse K; Lord C; Ramaiahgari S; Solomon GG; Shah RR; Pandiri AR; Herbert RA; Sills RC; Merrick BA
    BMC Genomics; 2018 Jun; 19(1):487. PubMed ID: 29925311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Is the Best NGS Enrichment Method for the Molecular Diagnosis of Monogenic Diabetes and Obesity?
    Philippe J; Derhourhi M; Durand E; Vaillant E; Dechaume A; Rabearivelo I; Dhennin V; Vaxillaire M; De Graeve F; Sand O; Froguel P; Bonnefond A
    PLoS One; 2015; 10(11):e0143373. PubMed ID: 26599467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
    Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
    J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics.
    Sikkema-Raddatz B; Johansson LF; de Boer EN; Almomani R; Boven LG; van den Berg MP; van Spaendonck-Zwarts KY; van Tintelen JP; Sijmons RH; Jongbloed JD; Sinke RJ
    Hum Mutat; 2013 Jul; 34(7):1035-42. PubMed ID: 23568810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance comparison of Agilent new SureSelect All Exon v8 probes with v7 probes for exome sequencing.
    Belova V; Shmitko A; Pavlova A; Afasizhev R; Cheranev V; Tabanakova A; Ponikarovskaya N; Rebrikov D; Korostin D
    BMC Genomics; 2022 Aug; 23(1):582. PubMed ID: 35962321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive assessment of Next-Generation Sequencing variants validation using a secondary technology.
    Zheng J; Zhang H; Banerjee S; Li Y; Zhou J; Yang Q; Tan X; Han P; Fu Q; Cui X; Yuan Y; Zhang M; Shen R; Song H; Zhang X; Zhao L; Peng Z; Wang W; Yin Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00748. PubMed ID: 31165590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient and tunable parameter to improve variant calling for whole genome and exome sequencing data.
    Ahn YJ; Markkandan K; Baek IP; Mun S; Lee W; Kim HS; Han K
    Genes Genomics; 2018 Jan; 40(1):39-47. PubMed ID: 29892897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
    Mu W; Lu HM; Chen J; Li S; Elliott AM
    J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
    Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanger sequencing is no longer always necessary based on a single-center validation of 1109 NGS variants in 825 clinical exomes.
    Arteche-López A; Ávila-Fernández A; Romero R; Riveiro-Álvarez R; López-Martínez MA; Giménez-Pardo A; Vélez-Monsalve C; Gallego-Merlo J; García-Vara I; Almoguera B; Bustamante-Aragonés A; Blanco-Kelly F; Tahsin-Swafiri S; Rodríguez-Pinilla E; Minguez P; Lorda I; Trujillo-Tiebas MJ; Ayuso C
    Sci Rep; 2021 Mar; 11(1):5697. PubMed ID: 33707547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Software-Assisted Manual Review of Clinical Next-Generation Sequencing Data: An Alternative to Routine Sanger Sequencing Confirmation with Equivalent Results in >15,000 Germline DNA Screens.
    Muzzey D; Kash S; Johnson JI; Melroy LM; Kaleta P; Pierce KA; Ready K; Kang HP; Haas KR
    J Mol Diagn; 2019 Mar; 21(2):296-306. PubMed ID: 30529126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluation of an amplicon-based next-generation sequencing panel for BRCA1 and BRCA2 variant detection.
    Park K; Kim MK; Lee T; Hong J; Kim HK; Ahn S; Lee YJ; Kim J; Lee SW; Lee JW; Lee W; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
    J Clin Lab Anal; 2020 Dec; 34(12):e23524. PubMed ID: 32812259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.
    Shin S; Hwang IS; Lee ST; Choi JR
    Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome Sequencing Starting from Single Cells.
    Andreou I; Storbeck M; Hahn P; Rulli S; Lader E
    Curr Protoc; 2024 Sep; 4(9):e70017. PubMed ID: 39324849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.